Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate

Severin Mairinger; Oliver Langer; Claudia Kuntner; Thomas Wanek; Jp Bankstahl; M Bankstahl; J Stanek; B Dörner; F Bauer; C. Baumgartner; W Löscher; T Erker; M Müller

doi:10.1016/j.nucmedbio.2010.02.008

Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate

Severin Mairinger
, Oliver Langer
, Claudia Kuntner
, Thomas Wanek
, Jp Bankstahl
, M Bankstahl
, J Stanek
, B Dörner
, F Bauer
, C. Baumgartner
, W Löscher
, T Erker
, M Müller

Molecular Diagnostics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	637-644
Number of pages	8
Journal	Nuclear Medicine and Biology
Volume	37
Issue number	5
DOIs	https://doi.org/10.1016/j.nucmedbio.2010.02.008
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Field

Former Research Field - Health and Bioresources

Access to Document

10.1016/j.nucmedbio.2010.02.008Licence: Unspecified

Cite this

Mairinger, S., Langer, O., Kuntner, C., Wanek, T., Bankstahl, J., Bankstahl, M., Stanek, J., Dörner, B., Bauer, F., Baumgartner, C., Löscher, W., Erker, T., & Müller, M. (2010). Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate. Nuclear Medicine and Biology, 37(5), 637-644. https://doi.org/10.1016/j.nucmedbio.2010.02.008

@article{5f4dc1c2c8754e039c42e9f6836a14ed,

title = "Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate",

author = "Severin Mairinger and Oliver Langer and Claudia Kuntner and Thomas Wanek and Jp Bankstahl and M Bankstahl and J Stanek and B D{\"o}rner and F Bauer and C. Baumgartner and W L{\"o}scher and T Erker and M M{\"u}ller",

year = "2010",

doi = "10.1016/j.nucmedbio.2010.02.008",

language = "English",

volume = "37",

pages = "637--644",

journal = "Nuclear Medicine and Biology",

issn = "0969-8051",

publisher = "Elsevier Inc.",

number = "5",

}

Mairinger, S, Langer, O, Kuntner, C, Wanek, T, Bankstahl, J, Bankstahl, M, Stanek, J, Dörner, B, Bauer, F, Baumgartner, C, Löscher, W, Erker, T & Müller, M 2010, 'Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate', Nuclear Medicine and Biology, vol. 37, no. 5, pp. 637-644. https://doi.org/10.1016/j.nucmedbio.2010.02.008

Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate. / Mairinger, Severin; Langer, Oliver; Kuntner, Claudia et al.
In: Nuclear Medicine and Biology, Vol. 37, No. 5, 2010, p. 637-644.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate

AU - Mairinger, Severin

AU - Langer, Oliver

AU - Kuntner, Claudia

AU - Wanek, Thomas

AU - Bankstahl, Jp

AU - Bankstahl, M

AU - Stanek, J

AU - Dörner, B

AU - Bauer, F

AU - Baumgartner, C.

AU - Löscher, W

AU - Erker, T

AU - Müller, M

PY - 2010

Y1 - 2010

U2 - 10.1016/j.nucmedbio.2010.02.008

DO - 10.1016/j.nucmedbio.2010.02.008

M3 - Article

SN - 0969-8051

VL - 37

SP - 637

EP - 644

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

IS - 5

ER -

Mairinger S, Langer O, Kuntner C, Wanek T, Bankstahl J, Bankstahl M et al. Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate. Nuclear Medicine and Biology. 2010;37(5):637-644. doi: 10.1016/j.nucmedbio.2010.02.008